Clinical signs, imaging, and biomarkers facilitate risk stratification for cardiac rupture in myocardial infarctionNew tools help doctors predict life-threatening heart ruptures after heart attacks

Cardiac rupture (CR) remains among the most lethal mechanical complications of acute myocardial infarction (AMI), with in-hospital mortality exceeding 50%. Although primary percutaneous coronary intervention has reduced CR incidence to 1%–2%, mortality has not declined proportionally because the abrupt onset of rupture limits the opportunity for intervention. The early post-infarction period—particularly the first 72 h for free wall rupture and extending through day 7 for ventricular septal and papillary muscle rupture—represents the critical window for detection. This mini review synthesizes clinical warning signs, point-of-care imaging findings, and circulating biomarker trajectories that may herald impending CR, organized by temporal window and rupture subtype. We evaluate emerging biomarkers reflecting inflammatory, extracellular-matrix-degradation, and myocardial-stress pathways, as well as artificial intelligence–assisted prediction tools. Building upon the prediction model synthesis by Mao et al. within this Research Topic, we propose a four-step risk stratification algorithm integrating baseline clinical predictors, dynamic three-track surveillance (clinical, imaging, and biomarker), red-flag–triggered risk re-classification, and subtype-specific diagnostic pathways. This framework is designed to bridge the translational gap between statistical risk estimation and actionable bedside recognition during the critical post-AMI period.